Pancreatic cancer vaccine study yields hopeful results, reviewed by Hopkins Dr.

0 Views

07/13/23

Most people don’t survive pancreatic cancer - it kills 88 percent of its patients.

But a study of a small group of cancer patients might hold some reassuring results.

Dr. Neeha Zaidi, an oncologist with Johns Hopkins' Kimmel Cancer Center, cares for pancreatic cancer patients, and helped peer-review the study.

"This study looks at a very hard disease," Zaidi said. "Pancreas cancer, which is resistant to most therapies."

A vaccine, the study shows, could help prevent the disease from happening again.

“Basically, what the vaccine does is, to teach, or to educate, one’s own immune system to recognize the cancer as foreign, and attack it," Zaidi told WMAR-2 News.

https://www.wmar2news.com/loca....l/pancreatic-cancer-